www.fdanews.com/articles/159870-germany-to-stop-assessments-of-pre-amnog-drugs

Germany to Stop Assessments of pre-AMNOG Drugs

November 6, 2013

Germany’s lawmakers have decided to stop benefit assessments of drugs that came to market before January of 2011, when the country’s AMNOG drug pricing law took effect.
BioCentury